1. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma
   Martin Mžik et al, 2016, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef
2. Methylation status of the promoter region of the human frizzled 9 gene in acute myeloid leukemia
   Yingjie Zhang et al, 2016, Molecular Medicine Reports CrossRef
3. GATA binding protein 5 (GATA5) induces Rho GTPase activating protein 9 (ARHGAP9) to inhibit the malignant process of lung adenocarcinoma cells
   Wenfei Ji et al, 2022, Bioengineered CrossRef
4. GATA4 inhibits cell differentiation and proliferation in pancreatic cancer
   Yan Gong et al, 2018, PLOS ONE CrossRef
5. Epigenetic signature of ionizing radiation in therapy-related AML patients
   Gráinne O'Brien et al, 2024, Heliyon CrossRef
6. Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathway
   Haiyan Wang et al, 2017, Oncotarget CrossRef
7. Genome-Wide Methylation Mapping Using Nanopore Sequencing Technology Identifies Novel Tumor Suppressor Genes in Hepatocellular Carcinoma
   Colin F. Davenport et al, 2021, International Journal of Molecular Sciences CrossRef
8. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells
   Jiaolin Liu et al, 2022, Bioengineered CrossRef
9. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes
   Haipeng Feng et al, 2019, Journal of Cellular and Molecular Medicine CrossRef